Gerlach U - Search Results

1

Electropharmacological characterization of cardiac repolarization in German shepherd dogs with an inherited syndrome of sudden death: abnormal response to potassium channel blockers.

Mérot J, Probst V, Debailleul M, Gerlach U, Moise NS, Le Marec H, Charpentier F. Mérot J, et al. Among authors: gerlach u. J Am Coll Cardiol. 2000 Sep;36(3):939-47. doi: 10.1016/s0735-1097(00)00811-1. J Am Coll Cardiol. 2000. PMID: 10987623 Free article.

2

Blockers of the slowly delayed rectifier potassium IKs channel: potential antiarrhythmic agents.

Gerlach U. Gerlach U. Curr Med Chem Cardiovasc Hematol Agents. 2003 Oct;1(3):243-52. doi: 10.2174/1568016033477469. Curr Med Chem Cardiovasc Hematol Agents. 2003. PMID: 15326915 Review.

3

Effects of chromanol 293B on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.

Du XL, Lau CP, Chiu SW, Tse HF, Gerlach U, Li GR. Du XL, et al. Among authors: gerlach u. J Mol Cell Cardiol. 2003 Mar;35(3):293-300. doi: 10.1016/s0022-2828(03)00007-5. J Mol Cell Cardiol. 2003. PMID: 12676544

4

Blockers of the ATP-sensitive potassium channel SUR2A/Kir6.2: a new approach to prevent sudden cardiac death.

Englert HC, Heitsch H, Gerlach U, Knieps S. Englert HC, et al. Among authors: gerlach u. Curr Med Chem Cardiovasc Hematol Agents. 2003 Oct;1(3):253-71. doi: 10.2174/1568016033477423. Curr Med Chem Cardiovasc Hematol Agents. 2003. PMID: 15326916

5

In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions.

Nakashima H, Gerlach U, Schmidt D, Nattel S. Nakashima H, et al. Among authors: gerlach u. Cardiovasc Res. 2004 Mar 1;61(4):705-14. doi: 10.1016/j.cardiores.2003.12.016. Cardiovasc Res. 2004. PMID: 14985067

6

Probing the contribution of IKs to canine ventricular repolarization: key role for beta-adrenergic receptor stimulation.

Volders PG, Stengl M, van Opstal JM, Gerlach U, Spätjens RL, Beekman JD, Sipido KR, Vos MA. Volders PG, et al. Among authors: gerlach u. Circulation. 2003 Jun 3;107(21):2753-60. doi: 10.1161/01.CIR.0000068344.54010.B3. Epub 2003 May 19. Circulation. 2003. PMID: 12756150

7

Rate- and site-dependent effects of propafenone, dofetilide, and the new I(Ks)-blocking agent chromanol 293b on individual muscle layers of the intact canine heart.

Bauer A, Becker R, Freigang KD, Senges JC, Voss F, Hansen A, Müller M, Lang HJ, Gerlach U, Busch A, Kraft P, Kübler W, Schöls W. Bauer A, et al. Among authors: gerlach u. Circulation. 1999 Nov 23;100(21):2184-90. doi: 10.1161/01.cir.100.21.2184. Circulation. 1999. PMID: 10571978

8

The new selective I(Ks)-blocking agent HMR 1556 restores sinus rhythm and prevents heart failure in pigs with persistent atrial fibrillation.

Bauer A, Koch M, Kraft P, Becker R, Kelemen K, Voss F, Senges JC, Gerlach U, Katus HA, Schoels W. Bauer A, et al. Among authors: gerlach u. Basic Res Cardiol. 2005 May;100(3):270-8. doi: 10.1007/s00395-005-0522-y. Epub 2005 Apr 1. Basic Res Cardiol. 2005. PMID: 15795798

9

Synthesis and activity of novel and selective I(Ks)-channel blockers.

Gerlach U, Brendel J, Lang HJ, Paulus EF, Weidmann K, Brüggemann A, Busch AE, Suessbrich H, Bleich M, Greger R. Gerlach U, et al. J Med Chem. 2001 Nov 8;44(23):3831-7. doi: 10.1021/jm0109255. J Med Chem. 2001. PMID: 11689069

10

HMR 1556, a potent and selective blocker of slowly activating delayed rectifier potassium current.

Thomas GP, Gerlach U, Antzelevitch C. Thomas GP, et al. Among authors: gerlach u. J Cardiovasc Pharmacol. 2003 Jan;41(1):140-7. doi: 10.1097/00005344-200301000-00018. J Cardiovasc Pharmacol. 2003. PMID: 12500032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters